In her practice and her teachings, Dr. Laurie Steelsmith blends the benefits of healing techniques from the Western naturopathic tradition with the ancient art of Chinese medicine. She is also a licensed naturopathic physician and acupuncturist. She is the Medical Director of Steelsmith Natural Health Center, a state-of-the-art healing center for natural medicine and author of the best-selling book Great Sex, Naturally.
The FDA is proposing regulations that would allow massive drug companies to eliminate your access to compounded bioidentical hormones. YOUR ACTION IS NEEDED! Recently, the FDA released a list of nominations to its “Demonstrably Difficult to Compound” (DDC) list. This list derives from section 503A of the Food, Drug, and Cosmetic Act. It is supposed to identify drugs that cannot safely be compounded because of their complexity. The agency is threatening to take away the ability of compounding pharmacies to provide estriol, progesterone and testosterone to their patients, despite the fact that they have been safely providing these prescriptions for over 30 years.
Flibanserin, sometimes referred to in the popular press as “female Viagra,” is a drug that is being touted as a non-hormonal treatment for pre-menopausal women with hypoactive sexual desire disorder (HSDD). In this podcast, Dr. Laurie Steelsmith discusses the complexities of female libido, the physiologic mechanism and risks associated with Flibanserin, as well as natural alternatives.
More women are turning to bioidentical hormone replacement therapy as a way to relieve the symptoms of menopause. The decision of whether to use hormone therapy has been made difficult by conflicting studies of the side effects of traditional hormone therapy. Bioidentical hormone replacement therapy uses naturally occurring hormones derived from plants and animals versus the synthetic compounds use in tradition hormone replacement therapy.